TRIM63 and neuromuscular disease caused by qualitative or quantitative defects of dysferlin: Calpainopathy patients demonstrate increased MuRF-1 expression [24,25], in patient with dysferlinopathy both atrogin-1 and MuRF-1 expression levels become increased [26].